Joseph Ciaffoni

CEO

Board Member CEO CEO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Collegium Pharmaceutical, Inc (COLL)	Former President and Chief Executive Officer	$364,423	—	$9,372,916	—	—	$952,513	$10,689,852
2023	Collegium Pharmaceutical, Inc (COLL)	Former President and Chief Executive Officer	$817,038	—	$7,691,315	—	$612,563	$22,008	$9,142,924
2022	Collegium Pharmaceutical, Inc (COLL)	Former President and Chief Executive Officer	$751,846	—	$5,231,750	—	$914,288	$19,646	$6,917,530
2021	Collegium Pharmaceutical, Inc (COLL)	President and Chief Executive Officer	$712,754	—	$6,214,320	—	$369,400	$17,861	$7,314,335
2020	Collegium Pharmaceutical, Inc (COLL)	President and Chief Executive Officer	$654,338	—	$3,755,681	$1,154,970	$460,000	$17,650	$6,042,639

Executive changes

Terminated President and Chief Executive Officer at Collegium Pharmaceutical, Inc (COLL)
2024-05-24

Earnings-call appearances

Indivior Pharmaceuticals, Inc. Q1 FY2026 Earnings Call
Indivior Pharmaceuticals, Inc. (INDV)

2026-04-30
Collegium Pharmaceutical, Inc Q1 FY2024 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2024-05-09
Collegium Pharmaceutical, Inc Q4 FY2023 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2024-02-22
Collegium Pharmaceutical, Inc Q2 FY2022 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2022-08-04
Collegium Pharmaceutical, Inc Q2 FY2021 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2021-08-05
Collegium Pharmaceutical, Inc Q3 FY2020 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2020-11-05
Collegium Pharmaceutical, Inc Q2 FY2020 Earnings Call
Collegium Pharmaceutical, Inc (COLL)

2020-08-05